Clinical Trial: Dose‐Finding Study of Linaprazan Glurate, A Novel Potassium‐Competitive Acid Blocker, Versus Lansoprazole for the Treatment of Erosive Oesophagitis
Authors
David Armstrong (ORCID: https://orcid.org/0000-0003-2487-1479)
Maria Rosenholm
A Rosztóczy (ORCID: https://orcid.org/0000-0002-8597-8934)
Clinical Trial: Dose‐Finding Study of Linaprazan Glurate, A Novel Potassium‐Competitive Acid Blocker, Versus Lansoprazole for the Treatment of Erosive Oesophagitis
David Armstrong, Maria Rosenholm, A Rosztóczy, Peter Unge et al.
Citations
3 citations
Journal
Alimentary Pharmacology & Therapeutics
Topics
Gastroesophageal reflux and treatments
Field-Weighted Citation Impact (FWCI)
5.43
article
Clinical Trial: Dose‐Finding Study of Linaprazan Glurate, A Novel Potassium‐Competitive Acid Blocker, Versus Lansoprazole for the Treatment of Erosive Oesophagitis
David Armstrong, Maria Rosenholm, A Rosztóczy, Peter Unge, Elham Yektaei, Prateek Sharma, Kjell Andersson, Michael F. Vaezi, Kajsa Larsson, Ivan Popadiyn
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
Alimentary Pharmacology & TherapeuticsVol. 61(10)
Institutions
University of Kansas (US), Vanderbilt University (US), University of Szeged (HU), Tokuda Hospital (BG), McMaster University (CA)